Introduction: In animal models, lipid emulsion therapy has been shown to ameliorate toxicity from a number of lipid soluble agents. This preliminary study addresses the hypothesis that pretreatment with lipid emulsion protects against propranolol toxicity in rodents.
INTRODUCTION
Propranolol is a beta blocker commonly involved in poisonings with this class of drug [1] . In addition to its lipophicity, the sodium channel blocking effect of propranolol-when compared to other beta blockers-is thought to contribute to increased mortality [1] [2] [3] . The magnitude of sodium channel blockade can be measured experimentally as a blockade of fast inward sodium channels results in a QRS prolongation on the surface ECG (4) .
In previous experiments, intravenous lipid emulsions have been shown to ameliorate the toxicity of a number of lipid soluble agents [5] [6] [7] [8] [9] [10] . A hypothesized mechanism is the formation of a new intravascular lipid phase that affects drug distribution.
This preliminary study tests the hypothesis that pretreatment with Intralipid ® (Pharmacia and Upjohn) 20%, an isotonic aqueous emulsion of 20% soybean oil in water, will protect against propranolol toxicity in rats.
Materials and Methods
Ethical approval was obtained from our local animal ethics committee. 10 female Rattus norvegicus rats (obtained from Ruakura Agresearch, Hamilton, New Zealand) weighing 217-285 grams were studied. The rats were raised in single sex conditions with no chance of pregnancy. There was no significant difference in mean weights between the control group (mean 253.4 gm, 95% C.I. 222.5 to 284.3) and the treatment group (mean 252.4 gm, 95% C.I. 240.3 to 263.6); (p = 0.91). Intralipid ® was obtained from the Monash Medical Centre pharmacy.
Animals were sedated using our institution's small animals protocol of 50 mg/kg ketamine and 0.1 mg/kg xylazine intraperitoneally. Once animals were adequately sedated, tail veins were cannulated with a 24 g cannula. For the course of the experiment animals were kept on a controlled temperature surface at 37 degrees Celsius.
Ten minutes after the intraperitoneal injection, heart rate sampling was begun using a 3 lead surface ECG at 50 mm/sec. Heart rates were calculated from a 3 beat interval measured on the rhythm strip to the nearest 0.5 mm.
After the initial ECG samples, animals were pretreated with either 16 ml/kg 20% Intralipid ® or 16 ml/kg 0.9% NaCl infused over 4 minutes. This dose was chosen because it was similar to the dosage used in previous work [7] . Every second experiment was a lipid pretreatment without any blinding of the primary investigator. ECG samplings were repeated following pretreatment. QRS duration was determined by scanning rhythm strips (50 mm/sec) at 120 pixels/cm. These were then magnified until pixelation, each pixel representing 0.00167 sec.
Animals were then infused with propranolol at 0.4 mg/kg/ minute. The main outcome variable was the total dose of propranolol to death, defined by the primary investigator as either absence of cardiac electrical activity or cessation of all respiratory effort. Work by Toet et al [11, 12] established that the mode of death in spontaneously ventilating rats infused with propranolol is respiratory depression.
Further analysis of data from the work of Toet et al [11, 12] showed that there were no significant differences in heart rate and blood pressure between ventilated and nonventilated rodents when 60% of mean lethal dose was used. Therefore, we chose as secondary outcome variables the heart rate and QRS duration when 60% of the mean lethal dose for control animals had been infused.
Data were analyzed using Graphpad Prism 4 ® (GraphPad Software, San Diego, CA). Statistical significance was set at a 2-tailed p value <0.05. The Mann-Whitney test was used for intergroup comparisons. Wilcoxon sum of ranks was used to compare intrasubject differences.
RESULTS
There were 5 rats in each of the Intralipid ® and saline pretreated groups. No significant difference was observed in heart rate or QRS duration following pretreatment [ Table 1 ].
The mean survival time during propranolol infusion in the Intralipid ® pretreated group was 47 minutes: (18.8 mg/kg total infused); (95% C.I. 4.5 to 89.75 min). The mean survival time in the saline pretreated group was 18.75 minutes: (7.5 mg/kg total infused); (95% C.I. 14.25 to 23 min). The difference was not significant (p = 0.15). Respiratory arrest was the mode of death in all subjects.
Compared to values at commencement of propranolol infusion, an analysis of percent change in QRS duration and heart rate at 4.8 mg/kg infused (12 minutes) suggested benefit to intralipid pretreatment on heart rate reduction, and a significant lessening of QRS duration prolongation [ Table 2 ]. This point was chosen as the sampling time most representative of 60% of the mean lethal dose of propranolol in controls, and all study animals survived to this point.
Discussion
These results suggest that lipid emulsion may be effective in ameliorating propranolol toxicity in rats. An increase in a lethal dose of propranolol in the lipid-pretreated animals was found, but the observed difference did not reach statistical significance.
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Assuming an effect as large as those demonstrated in this study, the same distribution parameters, and normality for survival time distributions, 27 animals would be needed in each arm to provide 80% power of demonstrating an effect on survival times at the 0.05 significance level.
There is a wide distribution of survival time in lipidpretreated animals, as evidenced by the 95% C.I. that was notably wider than controls. One hypothetical explanation is that Intralipid ® may have both protective effects on toxicity of propranolol, and it may have some independent toxic effects. Further studies may use a lipid only arm (no propranolol post pretreatment) to further evaluate this issue. Of note, a similar wide variability in effect of lipid pretreatment on bupivacaine toxicity in rats was noted [7] . A strong effect for lipid emulsion in treating bupivacaine toxicity was later shown in dogs [6] .
The effects of lipid emulsion were favorable on cardiac parameters measured at 60% of the mean lethal dose. We used our control data and analysis of previous work [11, 12] to establish 4.8 mg/kg as the most appropriate point for analysis of heart rate and QRS duration in our protocol. Because these endpoints were established retrospectively, they must be considered secondary outcomes.
Attenuation of propranolol-induced bradycardia in the fat emulsion group was observed at 4.8 mg/kg, which approached statistical significance. In previous animal studies, Intralipid ® administration has been associated with metabolic effects resulting in tachycardia [14, 15] . The non-significant reduction in heart rate post Intralipid ® pretreatment suggests these metabolic effects were not the cause for the protective effect of lipid. Further studies (using a lipid only arm) would be needed to properly evaluate the cause for the protective effect of lipid.
A significant effect preventing QRS duration prolongation suggests intralipid pretreatment protected against the local anaesthetic effects of propranolol. Although other mechanisms for QRS prolongation from propranolol-such as beta blockade or a central depressant effect [16] -could be forwarded, they would not alter the interpretation of the data showing beneficial effect for Intralipid ® on this parameter.
Previous work has demonstrated a beneficial role for fat emulsion therapy in the setting of lipid soluble drug toxicity. A pharmacokinetic mechanism has been hypothesized to explain these effects [5] [6] [7] [8] [9] [10] . The most impressive report to date involves a canine model of bupivicaine-induced cardiac arrest. In this study, all six dogs treated with lipid emulsion after 10 minutes of cardiac arrest were successfully resuscitated. In the control group, no dogs were successfully resuscitated [6] . Postulated mechanisms for observed effects of lipid emulsions on lipid soluble drug toxicity include creation of an intravascular lipid phase acting either as a drug depot or a conduit to metabolism or redistribution [5] [6] [7] [8] [9] [10] .
This study has a number of limitations: principally small numbers and an effect on total lethal dose that is not statistically significant. The principal investigator was not blinded to pretreatment. However, endpoints were objective, decreasing the potential for bias. While there is some evidence that ventilating rats would not have altered cardiac parameters at the point they were analysed [11, 12] , control of respiratory status with ventilation would have been preferable.
Interpretation
These results suggest lipid emulsion may be effective in ameliorating toxicity of propranolol in rats. Previous work provides a plausible pharmacokinetic mechanism to explain the beneficial effect.
The results represent encouraging exploratory work, and further work is planned to elucidate the role of lipid emulsion in treating propranolol toxicity.
